JP2019523226A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523226A5
JP2019523226A5 JP2018564844A JP2018564844A JP2019523226A5 JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5 JP 2018564844 A JP2018564844 A JP 2018564844A JP 2018564844 A JP2018564844 A JP 2018564844A JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5
Authority
JP
Japan
Prior art keywords
sbt
oil
pufa
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018564844A
Other languages
English (en)
Japanese (ja)
Other versions
JP7518604B2 (ja
JP2019523226A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/036330 external-priority patent/WO2017214260A1/en
Publication of JP2019523226A publication Critical patent/JP2019523226A/ja
Publication of JP2019523226A5 publication Critical patent/JP2019523226A5/ja
Application granted granted Critical
Publication of JP7518604B2 publication Critical patent/JP7518604B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018564844A 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 Active JP7518604B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662346755P 2016-06-07 2016-06-07
US62/346,755 2016-06-07
PCT/US2017/036330 WO2017214260A1 (en) 2016-06-07 2017-06-07 Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

Publications (3)

Publication Number Publication Date
JP2019523226A JP2019523226A (ja) 2019-08-22
JP2019523226A5 true JP2019523226A5 (enExample) 2020-07-27
JP7518604B2 JP7518604B2 (ja) 2024-07-18

Family

ID=60578981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018564844A Active JP7518604B2 (ja) 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法

Country Status (9)

Country Link
US (3) US10206875B2 (enExample)
EP (1) EP3463299A4 (enExample)
JP (1) JP7518604B2 (enExample)
CN (2) CN116019768A (enExample)
AU (1) AU2017277497B2 (enExample)
CA (1) CA3026412A1 (enExample)
IL (1) IL263504A (enExample)
MX (1) MX2018015112A (enExample)
WO (1) WO2017214260A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7518604B2 (ja) * 2016-06-07 2024-07-18 タルガジェニックス,インコーポレイテッド タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法
CA3121615A1 (en) * 2017-12-20 2019-06-27 Targagenix, Inc. Combination taxoid nanoemulsion with immunotherapy in cancer
JP7610208B2 (ja) * 2019-03-22 2025-01-08 インテグレイテッド ナノセラピューティクス インコーポレイテッド 足場部分から調製した脂質結合体
CN114599394A (zh) * 2019-10-25 2022-06-07 安进公司 用于在低蛋白浓度下使蛋白损失最小化的组合物和方法
CA3157484A1 (en) * 2019-11-05 2021-05-14 Ulagaraj Selvaraj Nanoparticles comprising prodrugs stabilized by albumin for treatment of cancer and other diseases
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂
CN114317398B (zh) * 2020-09-27 2024-03-01 中国科学院分子细胞科学卓越创新中心 Gli1和EpCAM基因共同标记的肝祖细胞群及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
CA2544128A1 (en) * 2003-10-30 2005-05-12 The Research Foundation Of State University Of New York Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations
EP2317978A2 (en) * 2008-07-23 2011-05-11 Bharat Serums And Vaccines Ltd. Stable injectable oil-in-water docetaxel nanoemulsion
US20100021471A1 (en) * 2008-07-25 2010-01-28 Brookhaven Science Associates, Llc Carbon nanotube-based drug delivery systems and methods of making same
US20140105829A1 (en) * 2012-10-15 2014-04-17 Nemucore Medical Innovations, Inc. Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same
US11197828B2 (en) * 2014-06-19 2021-12-14 Solural Pharma ApS Solid oral dosage form of lipophilic compounds
JP6634034B2 (ja) * 2014-06-25 2020-01-22 シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドSynergia Bio Sciences Private Limited 医薬水中油型ナノエマルジョン
JP7518604B2 (ja) * 2016-06-07 2024-07-18 タルガジェニックス,インコーポレイテッド タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法
CA3121615A1 (en) * 2017-12-20 2019-06-27 Targagenix, Inc. Combination taxoid nanoemulsion with immunotherapy in cancer

Similar Documents

Publication Publication Date Title
JP2019523226A5 (enExample)
Leyva-Gómez et al. Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art
Liu et al. Salidroside promotes peripheral nerve regeneration based on tissue engineering strategy using Schwann cells and PLGA: in vitro and in vivo
AU2015211711B2 (en) Orally administered agent for ruminants and ruminant feed containing same
Sonu Ambwani et al. Current knowledge on nanodelivery systems and their beneficial applications in enhancing the efficacy of herbal drugs.
Nie et al. Core/shell microspheres via coaxial electrohydrodynamic atomization for sequential and parallel release of drugs
Blanco-Llamero et al. Nutraceuticals and food-grade lipid nanoparticles: from natural sources to a circular bioeconomy approach
US20250009658A1 (en) Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
Mohapatra et al. Phytonanomedicine: A novel avenue to treat recurrent cancer by targeting cancer stem cells
Krsek et al. Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review
Sabzichi et al. Folate-targeted nanostructured lipid carriers (NLCs) enhance (Letrozol) efficacy in MCF-7 breast cancer cells
Bhushani et al. Nanodelivery of nutrients for improved bioavailability
Jahangir et al. Transdermal nutraceuticals delivery system for CNS disease
Rajan et al. Curcumin loaded in bovine serum albumin–chitosan derived nanoparticles for targeted drug delivery
Bozzuto et al. Phytocompounds and nanoformulations for anticancer therapy: A review
Liu et al. Advances in Transdermal Drug Delivery Systems and Clinical Applications in Inflammatory Skin Diseases
Yu et al. Highly water-dispersed and stable deinoxanthin nanocapsule for effective antioxidant and anti-inflammatory activity
Zhao et al. Electrospun gelatin nanocontainers for enhanced biopharmaceutical performance of piroxicam: in vivo and in vitro investigations
ES2992095T3 (es) Monoglicéridos de ácidos grasos poliinsaturados, composiciones y uso de los mismos para modular la composición de la microbiota de un sujeto
Upatcha et al. Nanoencapsulated cordyceps extract enhances collagen synthesis and skin cell regeneration through antioxidation and autophagy
JP2021517906A5 (enExample)
Garg et al. Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches
CN112040935A (zh) 诱导哺乳动物饱腹感的方法
de Oliveira Filho et al. Bioavailability and Delivery Mechanisms of Nutraceuticals in Nanoparticles Derived from Biopolymers
Castro-Pastrana et al. Recent Advances on Nanostructured Materials for Drug Delivery and Release